content

Industry Leaders Join Forces to Discuss Optimizing eConsent for Patient Centricity

Informative webinar hosted by CRF Health, a CRF Bracket company, will address how eConsent can be implemented effectively to support patient centricity and improve...

New Digital Marketplace for Life Science Products – Built with Scientists in Mind

Labviva, an AI-powered digital marketplace for life science reagents, instrumentation and services announces its launch to create scientifically informed purchasing decisions. ...

Eisai and UCLommence preparations for phase i clinical studies in Alzheimer’s Disease for Novel Anti-Tau Antibody

Eisai Co., Ltd  and University College London   announced  that they have commenced preparations for Phase I clinical studies on E2814 The...

AstraZeneca and Cancer Research UK launch Functional Genomics Centre to accelerate the discovery of new medicines

AstraZeneca announced a new collaboration with Cancer Research UK to launch a centre of excellence in genetic screening, cancer modelling and big data processing...

Phase 3 Trial of Rova T as Second-line Therapy for Advanced Small-Cell Lung Cancer Halted

AbbVie , a research-based global biopharmaceutical company, announced the decision to stop enrollment for the TAHOE trial, a Phase 3 study evaluating Rovalpituzumab Tesirine...

Pharma torch bearers congregate to select industry’s best in class in Mumbai

The India Pharma Awards, conducted by UBM India, India’s leading B2B exhibitions organizer, concluded the second and final round of jury selection at The...

Recipharm’s proprietary molecule Erdosteine recognised as COPD treatment

Recipharm has announced that its proprietary molecule Erdosteine has been officially recognised by the GOLD (Global Initiative for Chronic Obstructive Lung disease) Scientific Committee...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read